You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Get the latest updates or take a self-assessment.

LENV

Cancer Type: Endocrine, Thyroid      Intent: Palliative
Regimen Category: Evidence-Informed
Funding:
Exceptional Access Program
    For the treatment of patients with locally recurrent or metastatic, progressive, radioactive-iodine-refractory differentiated thyroid cancer (DTC) according to criteria

You might also be interested in